Arcus Biosciences, Inc.
RCUS
$10.53
$0.050.48%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 911.00M | 997.00M | 978.00M | 1.09B | 969.00M |
Total Receivables | 20.00M | 21.00M | 25.00M | 21.00M | 33.00M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 15.00M | 13.00M | 13.00M | 17.00M | 20.00M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 946.00M | 1.03B | 1.02B | 1.13B | 1.02B |
|
|||||
Total Current Assets | 946.00M | 1.03B | 1.02B | 1.13B | 1.02B |
Net Property, Plant & Equipment | 44.00M | 46.00M | 112.00M | 48.00M | 49.00M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 69.00M | 71.00M | 8.00M | 75.00M | 75.00M |
Total Assets | 1.08B | 1.16B | 1.15B | 1.25B | 1.19B |
|
|||||
Total Accounts Payable | 29.00M | 22.00M | 18.00M | 13.00M | 15.00M |
Total Accrued Expenses | 82.00M | 69.00M | 96.00M | 84.00M | 58.00M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 12.00M | 12.00M | 12.00M | 11.00M | 11.00M |
Total Finance Division Other Current Liabilities | 87.00M | 89.00M | 100.00M | 107.00M | 115.00M |
Total Other Current Liabilities | 87.00M | 89.00M | 100.00M | 107.00M | 115.00M |
Total Current Liabilities | 210.00M | 192.00M | 226.00M | 215.00M | 199.00M |
|
|||||
Total Current Liabilities | 210.00M | 192.00M | 226.00M | 215.00M | 199.00M |
Long-Term Debt | 118.00M | 69.00M | 48.00M | 68.00M | 20.00M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | 99.00M | -- | 118.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 198.00M | 364.00M | 292.00M | 404.00M | 214.00M |
Total Liabilities | 526.00M | 625.00M | 665.00M | 687.00M | 551.00M |
|
|||||
Common Stock & APIC | 1.79B | 1.78B | 1.62B | 1.60B | 1.58B |
Retained Earnings | -1.24B | -1.24B | -1.13B | -1.04B | -946.00M |
Treasury Stock & Other | -- | -- | -- | 1.00M | -1.00M |
Total Common Equity | 549.00M | 531.00M | 485.00M | 565.00M | 635.00M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 549.00M | 531.00M | 485.00M | 565.00M | 635.00M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 549.00M | 531.00M | 485.00M | 565.00M | 635.00M |
|